Litcius/Paper detail

Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation

Vinícius Campos de Molla, Vitor Heidrich, Júlia S. Bruno, Franciele Hinterholz Knebel, Wanessa Miranda‐Silva, Paula Fontes Asprino, Luciana Tucunduva, Vanderson Rocha, Yana Novis, Anamaria A. Camargo, Eduardo Rodrigues Fregnani, Celso Arrais‐Rodrigues

2021Scientific Reports22 citationsDOIOpen Access PDF

Abstract

Intestinal microbiota (IM) diversity and composition regulates host immunity and affects outcomes after allogeneic stem cell transplantation (allo-HSCT). We evaluated if the oral mucosa microbiota (OM) could impact the outcomes in patients who underwent allo-HSCT. Samples from the oral mucosa of 30 patients were collected at three time points: before the conditioning regimen, at aplasia, and at engraftment. We analyzed the associations of OM diversity and composition with allo-HSCT outcomes. Lower OM diversity at preconditioning was associated with a higher risk of relapse at 3 years (68% versus 33%, respectively; P = 0.04). Dominance (relative abundance ≥ 30%) by a single genus at preconditioning was also associated with a higher risk of relapse (63% versus 36% at 3 years, respectively; P = 0.04), as well as worse progression-free survival (PFS; 19% versus 55%, respectively; P = 0.01), and overall survival (OS) at 3 years (38% versus 81%, respectively; P = 0.02). In our study we observed that OM dysbiosis is associated with a higher risk of relapse and worse survival after allo-HSCT.

Topics & Concepts

Hematopoietic stem cell transplantationStem cellTransplantationHaematopoiesisImmunologyMedicineBiologyInternal medicineGeneticsOral health in cancer treatmentSalivary Gland Disorders and FunctionsOral Health Pathology and Treatment
Disruption of the oral microbiota is associated with a higher risk of relapse after allogeneic hematopoietic stem cell transplantation | Litcius